NOBILI, FLAVIO MARIANO
 Distribuzione geografica
Continente #
EU - Europa 51.191
AS - Asia 5.552
NA - Nord America 4.337
Continente sconosciuto - Info sul continente non disponibili 1.014
SA - Sud America 527
AF - Africa 118
OC - Oceania 15
Totale 62.754
Nazione #
IT - Italia 50.244
US - Stati Uniti d'America 4.046
SG - Singapore 2.272
CN - Cina 1.353
VN - Vietnam 877
BD - Bangladesh 471
FR - Francia 446
BR - Brasile 329
HK - Hong Kong 177
CA - Canada 117
FI - Finlandia 98
DE - Germania 86
AR - Argentina 83
GB - Regno Unito 74
JP - Giappone 68
MX - Messico 58
IN - India 52
IQ - Iraq 43
CH - Svizzera 39
ID - Indonesia 38
CO - Colombia 34
JM - Giamaica 30
ZA - Sudafrica 30
EC - Ecuador 29
ES - Italia 26
NL - Olanda 25
PH - Filippine 24
UA - Ucraina 24
CR - Costa Rica 23
IE - Irlanda 21
RU - Federazione Russa 21
PK - Pakistan 20
TR - Turchia 16
CL - Cile 15
TH - Thailandia 15
DZ - Algeria 14
TN - Tunisia 14
AU - Australia 13
EG - Egitto 13
UZ - Uzbekistan 13
MY - Malesia 12
SA - Arabia Saudita 12
TW - Taiwan 12
HN - Honduras 11
PL - Polonia 11
PY - Paraguay 11
KR - Corea 10
AT - Austria 9
BE - Belgio 9
MA - Marocco 9
NI - Nicaragua 9
VE - Venezuela 9
BY - Bielorussia 8
BO - Bolivia 7
GE - Georgia 7
KE - Kenya 7
SN - Senegal 7
GT - Guatemala 6
OM - Oman 6
RO - Romania 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
BS - Bahamas 5
PE - Perù 5
PR - Porto Rico 5
SV - El Salvador 5
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BB - Barbados 3
BH - Bahrain 3
ET - Etiopia 3
IL - Israele 3
IR - Iran 3
KH - Cambogia 3
LC - Santa Lucia 3
MD - Moldavia 3
MN - Mongolia 3
NG - Nigeria 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
CG - Congo 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GD - Grenada 2
GN - Guinea 2
Totale 61.706
Città #
Genova 29.911
Genoa 11.755
Rapallo 4.560
Vado Ligure 3.450
Singapore 1.050
San Jose 929
Ashburn 509
Lauterbourg 394
Ho Chi Minh City 284
Beijing 224
Hanoi 196
New York 195
Hong Kong 162
Santa Clara 149
Bordighera 110
Helsinki 95
Los Angeles 84
Rome 71
Council Bluffs 68
Frankfurt am Main 66
Tokyo 59
Chicago 55
Dallas 46
Orem 46
Buffalo 45
Zurich 38
Milan 36
Da Nang 35
Haiphong 32
Mexico City 31
Atlanta 30
Phoenix 28
São Paulo 26
Houston 22
Naples 22
City of London 21
Tianjin 21
Montreal 20
Amsterdam 19
Dublin 19
Kingston 19
Toronto 19
Philadelphia 18
Seattle 18
Biên Hòa 17
Brooklyn 17
Charlotte 17
San José 17
Washington 16
Denver 14
Miami 14
San Francisco 14
Baghdad 13
Boardman 13
Bogotá 13
Hải Dương 13
Johannesburg 13
Rio de Janeiro 13
San Antonio 13
Belo Horizonte 12
Guangzhou 12
Newark 12
Paris 12
Tashkent 12
Bologna 11
Des Moines 11
Kansas City 11
Las Vegas 11
Ninh Bình 11
Phủ Lý 11
Pittsburgh 11
Poplar 11
Shanghai 11
The Bronx 11
Bari 10
Catania 10
Chennai 10
Detroit 10
Manchester 10
Palermo 10
Princeton 10
Turin 10
Cardiff 9
Cleveland 9
Columbus 9
Florence 9
Greensboro 9
Jakarta 9
Kyiv 9
London 9
Managua 9
Mumbai 9
Quito 9
Santiago 9
Tunis 9
Brasília 8
Cairo 8
Changsha 8
Cincinnati 8
Guayaquil 8
Totale 55.611
Nome #
The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. 287
An updated Italian normative dataset for the Stroop color word test (SCWT) 277
A normative study of the Italian printed word version of the free and cued selective reminding test 234
Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease 227
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 219
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 218
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 218
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 215
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 214
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 205
Pulsatile electrical impedance response from cerebrally dead adult patients is not a reliable tool for detecting cerebral perfusion changes 205
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 204
Amyloid positron emission tomography and cognitive reserve. 204
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial 204
Neuroimaging findings in mild cognitive impairment 204
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. 203
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 203
99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease 201
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia 199
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 196
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 195
A repository based on a dynamically extensible data model supporting multidisciplinary research in neuroscience 195
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 193
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 193
Parkinson’s Disease Sleep Scale 2: application in an Italian population 192
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 192
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 191
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 187
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 187
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 185
A new frontier for amyloid PET imaging: multiple sclerosis 185
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 184
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 183
Cortical sources of awake scalp EEG in eating disorders 182
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 182
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 182
Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease 180
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 180
Psychological and social aspects in management of Alzheimer’s patients: an inquiry among caregivers. 180
Agomelatine Improves Apathy in Frontotemporal Dementia 179
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 179
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 178
123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study 178
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 178
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 177
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 177
18f-fluorodeoxyglucose positron emission tomography tracks the heterogeneous brain susceptibility to the hyperglycemia-related redox stress 177
Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer’s disease. A multicentric EEG study. 176
Early identification of MCI converting to AD: a FDG PET study 176
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 176
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 175
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 175
Enhancement of SPECT Reconstructions by Means of Coregistered MR Data 172
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 172
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) 172
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment 171
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 171
A kinetics-based approach to amyloid PET semi-quantification 171
Automatic Localization of the Hippocampal Region in MR Images to Asses Early Diagnosis of Alzheimer’s Disease in MCI Patients 171
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 169
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 169
What predicts cognitive decline in de novo Parkinson's disease? 168
Effectiveness of Florbetapir PET Imaging in Changing Patient Management 168
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 168
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 167
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 167
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 167
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium 167
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 167
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 166
Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis 166
ASSESSMENT OF DEMENTIA IN ETHNIC MINORITY PATIENTS IN EUROPE: A EUROPEAN ALZHEIMER'S DISEASE CONSORTIUM SURVEY. 165
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 165
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 165
Cerebral Haemodynamic changes induced by spinal cord stimulation in man 165
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 165
Fronto-parietal coupling of brain rhythms in mild cognitive impairment: A multicentric EEG study. 164
CORTICAL SOURCES OF RESTING EEG RHYTHMS IN MILD COGNITIVE IMPAIRMENT AND SUBJECTIVE MEMORY COMPLAINT. 164
New tracers and new perspectives for molecular imaging in Lewy body diseases 164
Cerebral Blood Flow and plasma free Tryptophan in cirrhotics with and without hepatic encephalopathy. 162
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 162
Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders. 161
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 161
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 161
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 161
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 159
HEMORHEOLOGICAL AND CEREBRAL BLOOD FLOW CHANGES INDUCED BY LDL- APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS. 159
Cerebral blood flow and somatosensory evoked response changes induced by spinal cord stimulation: preliminary follow-up observations 159
Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report 158
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 158
Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images 158
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 158
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 157
Brain glucose metabolism and cognitive function in patients with amnestic Mild Cognitive Impairment (MCI) 156
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia 156
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 156
Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: An electroencephalographic study. 155
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 155
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC 155
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 155
Totale 18.034
Categoria #
all - tutte 213.290
article - articoli 188.585
book - libri 0
conference - conferenze 20.850
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.855
Totale 426.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.573 147 340 477 591 197 441 278 1.268 335 502 284 713
2022/20235.386 498 324 75 545 853 985 17 432 995 95 492 75
2023/20242.858 181 369 60 357 262 434 183 179 154 71 158 450
2024/20258.154 252 668 247 543 1.174 880 775 1.164 355 366 736 994
2025/202614.155 1.817 370 750 981 1.756 1.416 2.293 647 1.137 1.260 864 864
2026/20271.421 1.421 0 0 0 0 0 0 0 0 0 0 0
Totale 62.754